Malaria CSO platform, GMS |Participation in malaria-related events
CSO representatives at 13th RAI RSC meeting 26-26 March, Phnom Penh, Cambodia
Highlighted, for the first time, CSOs from each country presenting their work contributed to the national program.
Cambodia, Dr Sok Pun presented that 63% of bednets distribution to the national program throughout the country, revealed of 8,977 hard to reach population, forest goers and MMP accessed malaria service. Moreover, 100% of HC utilizing MIS for reporting, and 14 provincial Special Malaria Elimination Task Forces reactivated. Read more
Lao PDR, Dr Soulany Chansy a CSO country representative presented the data of CSOs working to support National program to end malaria from the country by 2030. The contribution of 30% (17344/58,460) of cases had been tested, of this contribution, 38% (680/1810) of positive cases were reported from CSOs. Read more
Myanmar, Dr Phone Si Hein presented a successful contribution to the national malaria program. 994,023 suspected malaria cases tested, 33,717 confirmed cases treated. Of this 33% of tests and found 55% of positive cases were done by CSOs. Read more
Thailand, Alistair Shaw, Thailand's CSO representative presented - Thai CSO contribution to the national program (2018) through 3 key strategies:
1. Community resilience
2. Worksite interventions
3. Cross-border collaborations. Read more
Vietnam, Dr Khuat Thi Hai Oanh showed 3 CSOs working in 4 provinces with the highest number of malaria cases to support and contribute national program with 3 different approached. PSI: Private sectors, HPS: Villages health workers, VietMCI: Community Malaria Action Team (CMAT).
CSOs data gathering, the use of mobile phone technology follows:
- PSI: HNQIS for quality monitoring and DHIS for reporting
- HPA: supported VHWs for reporting
- VietMCI's: CMAT, REDCap for mapping, monitoring, reporting, TA
The visit to Myanmar during 18-22 March 2019. The platform together with close collaboration with PSI, URC, and Save the Children as Myanmar Steering Committee members had organized the field visit to Mandalay and Sagaing Region. The team had an opportunity to learn from the Mandalay regional health department related to the sub-national elimination plan and their challenges. We would like to thanks to PSI and IOM for taking a team to their implementation areas. Special thanks to Professor Dr Saw Lwin for his support of the visit.
Call for proposals: Canada Fund for Local Initiatives is now open for Cambodia, Lao People's Democratic Republic (PDR) and Thailand
The Embassy of Canada in Thailand and Canada’s Diplomatic Offices in Cambodia and Lao PDR have launched their annual call for proposals for the Canada Fund for Local Initiatives (CFLI).
Canada Fund for Local Initiatives is now open for Cambodia, Lao People’s Democratic Republic (PDR) and Thailand
Deadline: 5 April 2019
The CFLI is a program designed to support small-scale, high-impact projects in developing countries, which align with Global Affairs Canada’s thematic priority areas for engagement. The program is directed at projects conceived and designed predominantly by local partners. Projects are selected and approved by the relevant Canadian embassy or high commission. The CFLI also serves to support positive bilateral relations between Canada and recipient countries and their civil societies, by deepening contacts and supporting local endeavours.
For more information, please visit CFLI.
Call for experts:
The WHO Global Malaria Programme is currently issuing a call for experts to serve as members of the provide advice to WHO. Development Group. This roster will also be used as the basis to convene future evidence review groups and technical consultations to guidelines.
In 2018, the WHO Global Malaria Programme initiated an extensive review of WHO’s processes for developing and disseminating policy guidance on malaria. The overall objective is to deliver timely, high-quality guidance to malaria-endemic countries through processes that are more transparent, consistent, efficient and predictable.
Update from WHO:
Guideline for malaria vector control
Number of pages: 24
Languages: English, French
Publication in English
Publication in French
This document covers the TDR strategy for 2018-23. It lays out TDR’s focus on research for increased implementation and access, graphically displaying the impact pathway. TDR’s unique value is explained through its integration of three core areas: research, research capacity strengthening, and global engagement. The document also includes the principles, partnerships, governance and management practices behind the strategy, as well as a review of the Programme’s historical achievements.
Changes to WHO recommended procurement criteria for malaria rapid diagnostic tests:
WHO is announcing further revisions to the criteria used to determine procurement eligibility for antigen-detecting malaria rapid diagnostic tests (RDTs). Procurers and national malaria control programmes are encouraged to review their policies for future malaria RDT procurements and to align them with these revised recommendations.
New opportunities to prevent P. vivax malaria relapse
Tafenoquine has the distinct advantage of being a single-dose treatment, thereby increasing the likelihood of treatment compliance. There is, however, a key safety challenge associated with both tafenoquine and primaquine. Among patients who have a deficiency of the enzyme G6PD (glucose-6 phosphate dehydrogenase) – a genetic condition with a prevalence of up to 35% in some countries affected by P. vivax malaria – the drugs can trigger a severe blood disorder known as acute haemolytic anaemia.
After 10 years of implementation, there is a need of MEASURE Evaluation to document the process based on lessons learned and provide countries with a reference document for implementing these training, Furthermore, as the project comes to a close, the reference document will serve as a quick startup guide for future country malaria SME workshop implementation, including step-by-step approaches, practical tools, and troubleshooting.
Country-level malaria surveillance, monitoring, and evaluation (SME) systems. Since 2010, MEASURE Evaluation has offered a suite of training to contribute to the strengthening of
Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-Region
Pell CL, Adhikari B, Myo Thwin M, Kajeechiwa L, Nosten S, Nosten FH, Sahan KM, Smithuis FM, Nguyen TN, Hien TT, Tripura R, Peto TJ, Sanann N, Nguon C, Pongvongsa T, Phommasone K, Mayxay M, Mukaka M, Peerawaranun P, Kaehler N, Cheah PY, Day NPJ, White NJ, Dondorp AM, von Seidlein L
The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians.
BMC Infectious Diseases
Dysoley L, Kim S, Lopes S, Khim N, Bjorges S, Top S, Huch C, Rekol H, Westercamp N, Fukuda MM, Hwang J, Roca-Feltrer A, Mukaka M, Menard D, Taylor WR
The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial
von Seidlein L, Peto TJ, Landier J, Nguyen TN, Tripura R, Phommasone K, Pongvongsa T, Lwin KM, Keereecharoen L, Kajeechiwa L, Thwin MM, Parker DM, Wiladphaingern J, […], White NJ
This newsletter is distributed to over 100 international readers. Please let us know of any corrections or additions to our distribution list. Many of you are reading this on your mobile phones. Let us know if you have any difficulty downloading or accessing the newsletter. If you have any news or any feedback please contact BenjamasI@arcrelief.org